44th Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

43rd Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

42 Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

5th ESO-ESMO Advanced Breast Cancer (ABC5) International Consensus Conference

The International Consensus Conference for Advanced Breast Cancer (ABC) has established itself as a major international breast cancer conference. Its primary aim is the development of international consensus guidelines for the management of ABC patients. These guidelines are based on the most up-to-date evidence and can be used to guide treatment decision making in many different health care settings globally, with the necessary adaptations due to different access to care.

We believe that health professionals working closely together with patient advocates and with the strong support of media can raise awareness about the needs and challenges faced by this traditionally underserved and forgotten group of patients. ABC also aims to identify research priorities based on the most important areas of unmet need, analyse and discuss available data to provide the most accurate management recommendations, as well as influence policy makers and funding bodies and ultimately improve standards of care, survival and quality of life. Research and education, with accurate usage of available knowledge, throughout the world, are key to achieve these goals.

Komen® Oregon & SW Washington’s MBC Dinner Series

The Metastatic Breast Cancer Dinner Series provides a forum for people living with metastatic breast cancer to discuss the latest in research, treatment, and symptom management with local health experts, in a small group setting.

If you are unable to attend Dinner Series events in person, we will live-stream the presentation on our Facebook page (@KomenOregon). Individuals watching via the Facebook live video will be able to ask questions in the comments section, and they will be answered at the end of the speaker’s presentation.

Schedule:

6:15 PM – Check-in & Networking
6:45 PM – Dinner Served
7:00-8:30 PM – Presentation, followed by Q&A

2nd Annual Minneapolis Metsquerade

The Metsquerade is a fundraising event to benefit Metavivor. METAvivor is dedicated to the specific fight of women and men living with stage IV metastatic breast cancer. At the time of METAvivor’s founding, no organization was dedicated to funding research for the disease and no patient groups were speaking out about the dearth of stage 4 cancer research.  While more and more people have taken up the cry for more stage 4 research, METAvivor remains the sole US organization dedicated to awarding annual metastatic breast cancer research grants.

The Southwest Florida Metsquerade is one of many Metsquerades to sweep the nation and is dedicated to funding research for metastatic breast cancer (MBC). This is the only event of its kind where 100% of donations go to metastatic breast cancer research.

Komen® NYC Metastatic Breast Cancer Conference

Susan G. Komen Greater NYC invites you to join us for the New York Metastatic Breast Cancer Conference. In association with our conference partners, we are proud to offer two days of learning, fellowship, pampering and the most current information on treatments, research trials, patient support and national issues related to metastatic/stage IV breast cancer (MBC).

Thanks to the generous support of our sponsors, attendance is free. Advance registration is required.

Komen® Idaho Montana’s Metastatic Breast Cancer Dinner Series

The Metastatic Breast Cancer Dinner Series provides a forum for people living with metastatic breast cancer to discuss the latest in research, treatment, and symptom management with local health experts, in a small group setting. Join Komen Idaho Montana as we learn more about the metastatic breast cancer research and clinical trials being conducted at Oregon Health Science University by Komen Scholar, Dr. Joe Gray.

Free for those living with metastatic breast cancer and their guest. Registration is required.

Schedule:

5:30 PM – Dinner Served
6:30-7:30 PM – Presentation, followed by Q&A

Theresa’s Research Foundation’s MBC Conference

The mission of this conference is to bring together a diverse audience to create a collaborative research environment with a long term goal of developing curative approaches for metastatic breast cancer patients.

Background:

The Metastatic Breast Cancer Conference was established in 2014 as an annual medical conference for metastatic breast cancer by Theresa’s Research Foundation with leadership from Dr. Matthew Ellis and Dr. Danny Welch. The specific focus on metastatic disease is based on a major unmet clinical need (incurability); thereby distinguishing this conference from other breast cancer-centered conferences. The first conference was hosted at the University of Kansas Cancer Center. In 2015, 2016 and 2017 the MBCC was hosted at Baylor College of Medicine. The 2018 Conference was held at Johns Hopkins University School of Medicine. Additional leadership is provided by Dr. Xiang Zhang and the conference planning committee.

Up ↑